FUJIFILM Corp. has entered an agreement to acquire a cell therapy manufacturing facility from Atara Biotherapeutics, Inc. for $100 million. The facility located in Thousand Oaks, CA is readily expandable with the flexibility to produce both clinical and commercial cell therapies including allogeneic T-cell and CAR T immunotherapies.   FUJIFILM Diosynth Biotechnologies, a subsidiary of FUJIFILM Corp., a CDMO with experience in the development and manufacture of biologics, vaccines and advanced ...